Chris Kim - Apr 30, 2025 Form 3 Insider Report for Liminatus Pharma, Inc. (LIMN)

Role: Chief Executive Officer, Director, 10%+ Owner
Signature: /s/ Chris Kim
Stock symbol: LIMN
Transactions as of: Apr 30, 2025
Transactions value $: $0
Form type: 3
Date filed: 4/30/2025, 07:15 PM
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	LIMN	Common Stock, par value $0.0001 per share						6.17M	Apr 30, 2025	See Footnote	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Consists of shares of Common Stock of Liminatus Pharma, Inc. held of record by Valetudo Therapeutics LLC. Mr. Chris Kim is the CEO and controlling member of Valetudo and has voting and dispositive power over, and may be deemed to be the beneficial owner of, the shares held by Valetudo. Mr. Kim disclaims any beneficial ownership of any shares held by Valetudo except to the extent of his ultimate pecuniary interest therein.

Content

Consists of shares of Common Stock of Liminatus Pharma, Inc. held of record by Valetudo Therapeutics LLC. Mr. Chris Kim is the CEO and controlling member of Valetudo and has voting and dispositive power over, and may be deemed to be the beneficial owner of, the shares held by Valetudo. Mr. Kim disclaims any beneficial ownership of any shares held by Valetudo except to the extent of his ultimate pecuniary interest therein.